Background Oral leukoplakia (OL) is the most common oral potentially malignant disorder, yet despite its chronic and potentially disabling nature, the literature concerning impacts of OL on quality of life (QoL) is limited. This study aimed to evaluate QoL in subjects with OL compared to controls using QoL questionnaires. Methods Fifty individuals with OL and 50 controls matched for age, gender, smoking, and alcohol use were administered the Short Generic Health Questionnaire (SF‐12) and the discipline‐specific Oral Potentially Malignant Disorder Questionnaire (OPMDQ). Responses were compared between the two groups. Results Subjects with OL reported poorer QoL scores compared to controls in two domains “Role limitations due to physical problems” and “Pain” of the SF‐12 questionnaire, and in two domains “Difficulty with diagnosis” and “Effect of treatment on daily life” and in the overall scores of the OPMDQ. Females reported poorer QoL in the overall OPMD QoL score and in the domains of “Physical and function limitation” and “Psychological and social well‐being,” while older individuals in the domains of “Physical and function limitation” and “Effect of treatment on daily life.” Non‐alcohol drinkers and subjects with dysplastic or non‐homogeneous OLs also reported poorer QoL scores. Conclusions Quality of life assessments provide useful insight into the impact of OL on an individual's life and opportunity to improve clinical care.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.